Penumbral Rescue by Normobaric O2 Administration in Patients With Ischemic Stroke and Target Mismatch ProFile "PROOF"

Not yet recruiting

Phase 2 Results N/A

Summary of Purpose

The main objective of the PROOF trial is to investigate efficacy and safety of normobaric hyperoxygenation (NBHO) as a neuroprotective treatment in patients with acute ischemic stroke due to large vessel occlusion likely to receive endovascular mechanical thrombectomy (TBY) in a randomized controlled clinical phase IIb trial.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 April 2018.

1 Jun 2018 27 Mar 2018 1 Mar 2021 1 Jun 2021 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts